Steroid 21-hydroxylase deficiency is caused by defectiveness of the CYP21 gene. Such defects have presumably originated from interactions with the nearby CYP21P pseudogene during evolution. We studied these mechanisms by comparing the genetic variability of CYP21, CYP21P, and CYP21P/CYP21 hybrids (resulting from large-scale rearrangements) at eight mutation sites in a group of Dutch steroid 21-hydroxylase deficiency patients, their family members, and controls. The most common CYP21 defect in patients with salt-losing steroid 21-hydroxylase deficiency was a splice junction mutation in intron 2. The most common defect in the simple virilising form of the disease was ile72 → asn. CYP21P showed considerable sequence variation in its central and 3' sections; the 5' section was constant. A single nucleotide (T) insert in exon 7 was found in all CYP21P genes. During the course of evolution, this was probably the third defect introduced into CYP21P after the splice junction mutation in intron 2 and the 8 bp deletion in exon 3. Gene conversions introducing CYP21-like sequences contribute to CYP21P variability. Such an event has occurred de novo in one family. A comparison of CYP21 and CYP21P mutations on the same chromosome shows that at least some of the small-scale gene conversions that supposedly transfer defects to CYP21 involve interaction between homologous chromosomes. The majority of the putative CYP21P-CYP21 transitions in hybrid genes appears to occur in a distinct zone that lies 5' of nucleotide 2108, which is further downstream than previously hypothesised. The other transitions lie upstream of nucleotide 999. Apparent 'large-scale' CYP21-CYP21P gene conversions lead to hybrid genes that are very similar to those found in CYP21 deletions, so these haplotypes have probably resulted from a meiotic double unequal crossover.
Introduction
The human CYP21 gene, located on chromosome 6 (6p21.3), encodes the adrenocortical enzyme steroid 21-hydroxylase. 1 CYP21P is a pseudogene sharing 98% sequence homology with CYP21 but containing several alterations rendering it inactive.
2,3 CYP21 and CYP21P are about 30 kb apart and are part of a cluster of duplicated genes that includes genes encoding the fourth component of complement (C4) and tenascin-X. 1, 4, 5 Defectiveness of CYP21 leads to steroid 21-hydroxylase deficiency, which is the cause of over 90% of all cases of congenital adrenal hyperplasia. Complete deficiency results in severe salt-loss crises in untreated paediatric patients due to lack of aldosterone ('salt-losing') 21-hydroxylase deficiency), while increased androgen levels cause virilisation even in patients with less severe defects ('simple virilising' 21-hydroxylase deficiency). [6] [7] [8] Genetic analysis of steroid 21-hydroxylase deficiency is complicated by the existence of many different arrangements of CYP21 and CYP21P, including gene deletions, duplications, and large-scale gene conversions. Analysis of TaqI and BglII restriction patterns is commonly used to determine the gross arrangement of the CYP21/C4 region in steroid 21-hydroxylase deficiency patients and their family members. 1, [9] [10] [11] [12] [13] [14] [15] This approach allows the definition of CYP21/C4
haplotypes, some of which are associated with steroid 21-hydroxylase deficiency. [14] [15] [16] [17] [18] [19] [20] [21] [22] .
Three categories of defects can be distinguished:
(a) Haplotypes with a single gene that features a CYP21P-like TaqI restriction pattern ('CYP21 deletions'). These have resulted from a meiotic unequal crossover between CYP21 and CYP21P, creating a gene consisting of the 5' section of CYP21P and the 3' section of CYP21. 1, 9, [23] [24] [25] (b) Haplotypes with two genes, both with a CYP21P-like restriction pattern ('large-scale gene conversions').
Here, a section of CYP21 that includes at least the TaqI site in the 5' flank has been replaced by a CYP21P-like sequence. 10, 12, 13 (c) Haplotypes where a gene with a CYP21-like restriction pattern is present (by exclusion).
On chromosomes bearing steroid 21-hydroxylase deficiency, the CYP21 gene carries one or more deleterious mutations. 8, 17, [26] [27] [28] With a few exceptions, these mutations are found in the consensus sequence of CYP21P 2, 3 and have supposedly been transferred to CYP21 during evolution ('small-scale gene conversions'). The nature and the frequencies of the mutations in CYP21 have been well studied. They vary among different populations. 8, 17, 18, 22, [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] However, information on the variability of the CYP21P pseudogene, especially in association with the TaqI/BglII haplotypes that define the overall structure of the region, is rather limited. 18, 38 Such information is highly relevant to the hypotheses describing the origin of the different categories of disease-causing mutations in CYP21: the location of crossover sites and the extent of conversion zones depend on the composition of the CYP21P gene involved. We compared CYP21 and CYP21P in a single population, to assess the consequences of CYP21P variability for the hypothetical concepts of 'hybrid genes' and 'gene conversions'. The distribution of the 10 most common CYP21 defects (gene deletion, large-scale conversion, and eight mutations) was determined in 38 steroid 21-hydroxylase deficiency patients from The Netherlands, a population which has not been studied before. The sites corresponding to these mutations were also studied in CYP21P in these families, and in 46 controls having only one CYP21P gene.
Methods
Patients, family members, and controls Steroid 21-hydroxylase deficiency patients, their parents, and any available sibs from 38 families were included; in six families, only one of the parents was available. The number of independent chromosomes was 150 (due to consanguinity between two of the families), 75 of which carried a steroid 21-hydroxylase deficiency allele. Single patients and two families with apparent de novo gene rearrangements were not included. There were 29 families with salt-losing (SL) patients and nine families with simple virilising (SV) patients. From our group of 143 healthy controls from the general Dutch population, 46 had a heterozygous deletion of CYP21P and were selected for study of CYP21P separately. All subjects were informed about the purpose of the study and gave their consent.
Haplotyping and mutation analysis
TaqI and BglII restriction analysis 1,9-15 was used as described earlier 19 to establish CYP21/C4 haplotypes in all families and controls. Polymerase chain reaction (PCR) amplification of CYP21 and CYP21P followed by oligonucleotide hybridisation 17, 18, [27] [28] [29] was used to determine sequence variability.
Three overlapping parts of either CYP21 or CYP21P (see following sections 1, 2 and 3; Figure 1 ) were specifically amplified using the primers listed in Table 1 . PCR conditions (annealing temperature, number of cycles, MgCl 2 concentration) were: CYP21, section 1: 54°C, 30 cycles, 2.5 mM; CYP21P, section 1: 55°C, 32 cycles, 2.5 mM; CYP21, section 2: 55°C, 33 cycles, 2.5 mM; CYP21P, section 2: 57°C, 32 cycles, 2.5 mM; CYP21, section 3: 56°C, 32 cycles, 2.4 mM; CYP21P, section 3: 56°C, 32 cycles, 2.4 mM. All reactions were done with 1 unit of GoldStar DNA polymerase (Eurogentec, Seraing, Belgium) in a final volume of 50 µl in the presence of 2% formamide. In each case, the reverse primer was non-specific (not distinguishing between CYP21 and CYP21P) and downstream of the forward primer of the next section. The specificity of each reaction was checked by digesting 20% of the amplified product with PvuII (section 1), NdeII (section 2), or PstI (section 3), followed by electrophoresis in 2-2.5% agarose gels. These restriction sites are normally present in CYP21 and absent from CYP21P. Section 1 was also digested with EcoRI; the EcoRI site is specific for CYP21P (see Figure 1) . The PvuII and EcoRI restriction patterns of the section 1 PCR were matched to the bands shown by TaqI/PvuII and TaqI/EcoRI double digests of genomic DNA. 39, 40 Control samples containing or not containing these sites were included in each reaction. The results for section 1 were confirmed by amplification of CYP21 and CYP21P in a single reaction using the same (non-specific) reverse primer and a non-specific forward primer (see Figure 1 ; 53°C, 32 cycles, 3 mM MgCl 2 ) followed by EcoRI digestion to distinguish between CYP21 and CYP21P, Southern blotting and hybridisation as described elsewhere. 40 The remainder of the product was slot-blotted , and mutations were detected by hybridisation to allelespecific oligonucleotides, some of which were also used for amplification (see Table 1 and Figure 2 ).
Results

Arrangement of CYP21/CYP21P and complement C4 genes
An overview of the CYP21/CYP21P arrangements in the 38 families and 143 controls investigated is presented in Table 2 . Several CYP21/C4 haplotypes not described in our earlier report 19 were detected in the larger population now studied. Three controls had two CYP21 genes and no CYP21P genes on one chromosome, suggesting a 'large-scale' conversion of CYP21P to CYP21. Both C4 genes were 'long' (22 kb) in this haplotype. One control carried one CYP21 gene, three CYP21P genes, one long C4 gene and three short (16 kb) C4 genes on one chromosome. The mother of one patient had one CYP21 gene, three CYP21P genes and four 'long' C4 a the final wash in the oligonucleotide hybridisation was 20 min at these conditions; b primer site chosen about 100 bp upstream of the CYP21 primer, to include the EcoRI site in exon 2; c section 3 of genes carrying lys glu glu lys236 was amplified normally using this primer, but it was easily washed off in the hybridisation experiments of the section 2 PCR product.
CYP21 and CYP21P variability PFJ Koppens et al y genes on one chromosome. These unusual haplotypes were confirmed by SacII digestion and pulsed field gel electrophoresis (unpublished observations).
Polymerase chain reaction and oligonucleotide hybridisation
The PvuII and EcoRI restriction patterns for section 1 matched the genomic TaqI/PvuII and TaqI/EcoRI results in each case. The specificity of the amplification of section 2 could then be deduced from the mutation analysis of section 1, which contains its forward primer sites. Similarly, section 2 contains the forward primer site of section 3. This strategy allowed assignment of each sequence variant to either CYP21 or CYP21P in all cases.
Mutation detection by oligonucleotide hybridisation to slot blots or Southern blots usually produced straightforward results, with the exception of the (non-defective) 'C' variant at nucleotide 655 (the site of the splice junction mutation in intron 2; see Figure 2 ), which hybridised poorly and required careful washing steps. Similar weak signals with the 'C' variant were found by Rumsby et al. 41 The 'C' variant was readily detected in individuals homozygous for it, but the hybridisation signal was much weaker when the other chromosome carried either 'A' or 'G'. The (normal) 'A' and (defective) 'G' variants performed equally well in this analysis. In each parent carrying the 'G' allele on one chromosome, a non-defective ('A' or 'C') allele could also be detected, indicating that drop-out of one allele in the PCR 42 did not occur here. On the other hand, the amplification of both genes in a single reaction often produced a higher amount of CYP21P (containing 'G') than CYP21, especially when one or both of the CYP21 genes carried a 'C' at nucleotide 655. . The characteristics of the consensus CYP21 gene at each mutation site are, respectively: A or C at the splice junction mutation; no 8 bp deletion; ile172; ile val glu met236; val281; no 1 bp insertion; gln318; arg356. The characteristics of the consensus CYP21P gene are: G; 8 bp deletion; asn172; asn glu glu lys236; leu281; 1 bp insertion; stop318; trp356. The limits of the putative CYP21P-CYP21 transition zones have been drawn at arbitrary places relative to ile172/asn172 (zone a, 5' limit) and arg356/trp356 (zone b, 3' limit), respectively, since no further distinction is possible because the sequences of CYP21 and CYP21P are equal there. The arrows indicate that the actual transition site within these zones may vary for each hybrid. Bottom: hybrid genes with transition zones a and b, respectively; the hatched section is CYP21P-like. CYP21 and CYP21P variability y CYP21 mutations In 89% of the patients' CYP21 genes, the defect could be attributed to one of the deleterious mutations investigated here (see Table 3 ). In general, there was a good match between phenotype and genotype: a severe defect (deletion, large conversion, intron 2 splice mutation, 8 base pair deletion, asn glu glu lys236, 1 base pair (T) insertion, stop318, trp356 -mutation group A in the classification of Speiser et al 28 ) was found on both chromosomes in 25 out of 29 families with the salt-losing variety of the disease. None of the SV patients had one of the more severe defects on both chromosomes. The EcoRI site in intron 2 was not found in any CYP21 gene. The PvuII site in intron 2 was missing from one CYP21 gene that also carried the splice junction mutation, suggestive of a small-scale conversion transferring both alterations. One patient had both the 1 bp insertion in exon 7 and stop318 in exon 8, which were probably transferred from CYP21P in a single event during evolution. Two patients had val281 → leu, the 1 bp insertion (codon 306-307), gln318 → stop, and arg356 → trp in the CYP21 gene, suggesting that a single conversion event has occurred in the past to introduce these defects into CYP21.
One patient had a defective allele with two CYP21 genes. This haplotype carried the intron 2 splice junction mutation and gln318 → stop, and is probably the same as a haplotype described in the Swedish population.
43
CYP21P mutations CYP21P mutation analysis was complicated by the lack of clinical association and by the relatively frequent occurrence of chromosomes with more than one CYP21P gene. Only mutations that could be assigned to a specific haplotype with certainty were included. The distribution of CYP21P mutations in the most common haplotypes is shown in Table 4 .
On 36 chromosomes where the CYP21 defect was found, at least one CYP21P gene was present. On 32 of these chromosomes, there was a match between the CYP21 defect and the CYP21P sequence at the corresponding site -in these cases, CYP21P matched the consensus sequence. 2 Four CYP21 genes had a defect not found in the accompanying CYP21P gene. These were: leu281 and stop318 and trp356 on CYP21 vs val281 on CYP21P; leu281 and stop318 and trp356 on CYP21 vs arg356 on CYP21P; trp356 on CYP21 vs lys glu glu lys236 and val281 and arg356 on CYP21P; and trp356 on CYP21 vs val281 and arg356 on CYP21P. Seven chromosomes carried a defective CYP21 gene but no CYP21P gene. The CYP21 defects were: all four asn glu glu lys236 mutations; two of the intron 2 splice junction mutations; and one stop318 mutation.
The variation in the central and 3' sections of 'normal' CYP21P genes (ie CYP21P genes on the CYP21-CYP21P haplotype) was considerable. The most frequent deviations from the consensus CYP21P sequences were lys glu glu lys236, val281, gln318, and arg356. On the other hand, the T insert between codons 306 and 307 in exon 7 was present in all pseudogenes on the CYP21-CYP21P haplotype.
Many CYP21P genes carry more than one mutation as compared with the consensus sequences. 2, 3 The following combinations were found in the control group of individuals with a single CYP21P gene, where they could be unambiguously linked: asn glu glu lys236-leu281-stop318-trp356 (20 ϫ ); asn glu glu lys236-leu281-stop318-arg356 (8 ϫ ); lys glu glu lys236-val281-stop318-arg356 (8 ϫ ); asn glu glu lys236-leu281-gln318-arg356 (4 ϫ ) asn glu glu lys236-leu281-gln318-trp356 (1 ϫ ); asn glu glu lys236-val281-stop318-arg356 (1 ϫ ). Additional combinations were found in the family studies: of the 16 possible combinations of asn glu glu lys/lys glu glu lys236, leu/val281, stop/gln318 and trp/arg356, only lys glu The numbers refer to the independent chromosomes carrying the steroid 21-hydroxylase deficiency allele (see text); a a G at position 655, of the remaining genes, 83 had an A and 18 a C (equally distributed between SL and SV patients); b in one of these genes, the milder defect pro30 ¡ leu was detected in a separate experiment (results not shown); c one fewer than expected for 29 families due to known consanguinity (see text).
CYP21 and CYP21P variability PFJ Koppens et al y glu lys-leu-gln-trp, lys glu glu lys-val-gln-trp, lys glu glu lysleu-gln-arg, and lys glu glu lys-leu-stop-arg were not found. One CYP21P gene carried both ile172 and arg356; another carried both ile172 and ile val glu met236. There were no statistically significant differences in the frequencies of the CYP21P mutations between 'standard' (CYP21-CYP21P) chromosomes with functional or non-functional CYP21 genes, or between 21-hydroxylase deficiency families and controls. Table 5 shows all combined mutations on haplotypes carrying a single CYP21P-like gene (CYP21 'deletions') or two CYP21P-like genes ('large scale' CYP21 conversions). All these genes are CYP21P-like from their 5' flank to, at least, the 8 bp deletion in exon 3, and therefore defective.
De novo CYP21P mutation in one family
In a family with two patients each having two CYP21P genes, one patient carried ile val glu met236 on one chromosome and asn glu glu lys236 on the other, whereas all other family members only had asn glu glu lys236 on their CYP21P genes.
Paternity was confirmed by testing independent genetic markers (results not shown). All other investigated mutations and the CYP21/C4 haplotypes were inherited in a normal Mendelian fashion in this family. A de novo conversion event locally changing CYP21P to a CYP21-like sequence is the most obvious explanation. All CYP21 genes in this family carried ile val glu met236.
Discussion
Mutations in the CYP21 gene
The CYP21 mutations causing salt-losing 21-hydroxylase deficiency occurred at frequencies similar to those observed in other populations, the intron 2 splice mutation (a 'G' at nucleotide 655) being the most common. The frequency distribution is different for simple virilising 21-hydroxylase deficiency, where ile172 → asn is clearly more abundant. This finding is in agreement with some studies; 18, 28, 33, 34 others found the intron 2 splice mutation more often in simple virilising patients as well. 17, 22, 26, 36 The chance that a randomly selected Dutch individual who is a carrier of salt- The mutations are grouped per site; the variant matching the consensus sequence is mentioned first. The frequency of each mutation per haplotype is shown in percentages. The numbers in each column heading refer to the CYP21P genes, not to the chromosomes: for the haplotypes CYP21-CYP21P-CYP21P and CYP21P-CYP21P, the number of chromosomes is half the number of CYP21P genes. Mutations were only counted when they could be assigned to a haplotype with certainty. a steroid 21-hydroxylase deficiency families, numbers for chromosomes carrying and not carrying steroid 21-hydroxylase deficiency were added, 'standard' CYP21-CYP21P haplotypes, n=90 for val/leu281, n=93 for gln/stop318 and for arg/trp356; b controls with CYP21-CYP21P on one chromosome and a CYP21P deletion on the other, n=46 for mutations upstream of and including the 8 bp deletion, n=42 for the remaining mutations; c steroid 21-hydroxylase deficiency patients; hybrid genes due to a 30 kb deletion; n=12 for val/leu281, n=14 for arg/trp356; d patients, hybrid genes due to a large-scale gene conversion (two CYP21P genes were counted per chromosome), n=14 for val/leu281, n=16 for gln/stop318, n=12 for arg/trp356; e families, numbers for chromosomes carrying and not carrying steroid 21-hydroxylase deficiency were added, CYP21P duplication (two CYP21P genes were counted per chromosome), n=8 for val/leu281 and the arg/trp356. CYP21 and CYP21P variability y losing steroid 21-hydroxylase deficiency can be detected by analysis of the mutations described here, is about 95% (Table 3 ). This degree of certainty is unlikely to become much higher by checking additional mutations because de novo events are relatively frequent (in our population, twice in 40 families). In all patients described here, a genetic defect was found on at least one of both CYP21 alleles. Nondetection of both mutations in a single patient is unlikely, so it may indicate clinical misdiagnosis of steroid 21-hydroxylase deficiency.
Variability and evolution of CYP21P
CYP21P is constant in its 5' section up to and including the 8 bp deletion in exon 3, but shows considerable variation in its central and 3' parts even on 'standard' chromosomes carrying one copy of CYP21 and CYP21P each. The evolutionary origin of CYP21P variability is uncertain. The concept of 'back conversions' has been proposed to introduce CYP21-like sequences into CYP21P. 44 A de novo mutation introducing ile val glu met236 into CYP21P (not previously described in the literature) was observed in one 21-hydroxylase deficient patient, so 'back conversions' evidently play a role in maintaining CYP21P variability.
It is assumed that the duplicated arrangement of the CYP21-C4-TNX gene cluster has resulted from unequal crossover events that occurred independently in primates and other mammals during evolution. 4, 5, 45, 46 Therefore, CYP21-like sequences in the pseudogene may also be a leftover predating such a duplication. Comparison of primate CYP21P genes 45 suggests that after the duplication, deleterious mutations gradually accumulated in the gene now known as CYP21P. The splice junction mutation in intron 2 (found in the gorilla) was first introduced into the pseudogene, the 8 bp deletion in exon 3 (found in the chimpanzee) came next, and other mutations (only found in humans) followed later. The T insertion in exon 7 seems to be the next in line, because it is found in all CYP21P genes on normal (CYP21-CYP21P) chromosomes. Two previous studies 18, 38 found no variation at this site on the CYP21-CYP21P haplotype. The evolution of CYP21P may be further clarified by determining whether the T insert is ubiquitous in other human (especially, non-Western) populations as well. CYP21P variability may influence the outcome of smallscale gene conversions, because the physical conversion zone may extend beyond the region of similarity between a mutated gene and the CYP21P consensus sequence. In addition, CYP21P variability may contribute to the creation 
Mechanisms of small-scale gene conversions
By analogy to fungal genetics, the term gene conversion is used in higher eukaryotes to describe a non-reciprocal transfer of genetic information. The presence of CYP21P-like defects in CYP21 is usually attributed to a gene conversionlike mechanism, although donor and recipient can only be studied directly in case of a de novo event. Collier et al 24 described a de novo ile172 → asn conversion from CYP21P to CYP21; all CYP21P genes involved carried asn172. The opposite, a de novo conversion from CYP21 to CYP21P described in this report, was also non-reciprocal: asn gluglu lys236 was changed to ile val glu met, while all CYP21 genes retained ile val glu met. The necessary interaction between CYP21P and CYP21 may occur either between sister chromatids or between homologous chromosomes, but the distinction could not be made in the two de novo conversions mentioned above, because all potential donor sequences were identical. Since small-scale gene conversions are primarily mitotic processes, 25 sister chromatid interaction might be expected to provide the donor sequence. Four of the chromosomes studied here carried a CYP21 defect not found in the CYP21P gene on the same chromosome. In these cases, CYP21P matched the consensus non-mutated CYP21 sequence at the sites involved, and cannot have provided the donor sequence for the CYP21 conversion. This implies that at least some of the small-scale gene conversions involve interactions between homologous chromosomes rather than between identical sister chromatids.
CYP21P-CYP21 transition zones in hybrid genes
Absence of the CYP21 gene (as judged by TaqI/BglII restriction analysis) is one of the major causes of steroid 21-hydroxylase deficiency. Allowing for rare exceptions, 16 there are two main categories of chromosomes without a CYP21 gene: those with one, and those with two CYP21P genes. Chromosomes with one CYP21P gene (CYP21 deletion; Table 5 , middle) carry a single hybrid gene that has a CYP21P-like 5' section and a CYP21-like 3' section. Differences between the CYP21 and CYP21P consensus sequences (Table 5 , top) have frequently been used to define a putative CYP21P-CYP21 transition zone, and thus to determine the breakpoint of the unequal crossover that created these hybrids during the course of evolution. However, several of such landmarks (val281, gln318, arg356, and to some degree even ile172 and ile val glu met236) are not necessarily specific for CYP21 on normal chromosomes, but appear in CYP21P as well (Table 4 ). This causes ambiguity in locating the 5' limit of CYP21P-CYP21 transition areas (unless a de novo mutation is available for analysis).
Two crossover regions have been proposed for hybrid genes: (a) between the 8 bp deletion in exon 3 and the ile172 → asn site in exon 4, and (b) between the end of exon 7 and the gln318 → stop site in exon 8. 23, 35, 47 In our patient group, the breakpoint lies in zone (a) in the families 8, 9, and 17 (see Table 5 ). Zone (a) extends further upstream, because it has been shown that de novo recombinations can also occur upstream of the 8 bp deletion in exon 3. 25 In the other 12 families with the 'deletion' haplotype, the breakpoint cannot lie immediately downstream of exon 7, because several of the hybrid genes carry either stop-318 or trp-356 instead of the expected CYP21-like sequence. We therefore hypothesise that the second putative conversion zone (b) lies downstream of the arg356 → trp site (see Figure 2) , and that the differences between these haplotypes can be explained by variation between the CYP21P genes involved in the crossover. This model also explains the variability at the other sites listed in Table 5 , and the differences at the val281 → leu and gln318 → stop sites previously found in the analysis of several HLA-B47 haplotypes. 35, 47 However, the alternative of later introduction of these mutations in a pre-existing HLA-B47 associated hybrid gene cannot be excluded. A reliable marker for distinguishing between conversion zone (a) and conversion zone (b) in hybrid genes, is the absence (zone a) or presence (zone b) of the T insert in exon 7. Chromosomes with two CYP21P genes ('large-scale conversions'; Table 5 , bottom) carry one regular CYP21P gene and one CYP21P-CYP21 hybrid. The transition zones in the hybrid gene are the same as for the 'single' hybrid genes described above: zone (a) in families 3, 14 (one of the two chromosomes), and 28, and zone (b) in the other cases.
Tusié-Luna and White 25 have found that de novo unequal crossovers leading to CYP21 deletions occur during meiosis only. However, this also applies to apparent 'large-scale conversions', because the hybrid genes found in CYP21 deletions and in large-scale conversions are so similar (see Table 5 ) that the PCR amplification used in that study does not distinguish between them. Since CYP21 'deletions' and 'large scale' conversions are both meiotic and result in a very similar layout of the CYP21P-CYP21 hybrid gene, they are probably created by similar processes. We therefore hypothesise that large-scale gene conversions of CYP21 to a CYP21-CYP21P hybrid are actually meiotic double unequal crossovers. One putative crossover site lies within region (a) or (b) as shown in Figure 2 , the other one lies upstream of the TaqI restriction site at nucleotide -211 in the 5' flank. Interestingly, the other product expected from such an event, a chromosome with two CYP21-like genes and no CYP21P-like genes, was found in three healthy controls. Contrary to the single unequal crossovers that lead to deletions and duplications of CYP21 or CYP21P, 1, 5, 6, 9, 23 the proposed double unequal crossover does not alter the number of C4-CYP21-TNX units or the overall size of the region.
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Conclusions
Our mutation analysis detects 95% of all defects causing saltlosing steroid 21-hydroxylase deficiency in The Netherlands, and hence provides a guideline for the diagnosis of the most severe form of this disease in the Dutch population. CYP21P shows a high variability, and non-consensus CYP21P genes are widespread in the general population. This necessitates a revised definition of CYP21P-CYP21 transition zones in gene conversions and unequal crossovers generating CYP21 defects.
At least some of the small-scale gene conversions between CYP21 and CYP21P involve interaction between homologous chromosomes. Large-scale gene conversions appear to be the result of a completely different genetic mechanism: these rearrangements are probably generated by a meiotic double unequal crossover.
Future research on the genetic mechanisms underlying the variability in the CYP21/complement C4 region should take account of the high variability of the CYP21P pseudogene. This notably applies to the study of de novo mutations, where information on donor and recipient DNA can be obtained more easily than in population studies.
